European Wound-Management Market to Expand

The advanced wound-management market is forecast to grow 12.4% over the next seven years, reaching U.S.$1.2 billion in 2010, according to a new report from Frost & Sullivan (Palo Alto, CA, USA), an international consulting firm.

The market is being spurred by innovation, rising acceptance by healthcare decision makers, and the prospect of enhanced clinical and cost efficiencies. This is being paralleled by a decline in the traditional wound management market. Continued research and development in the three main product segments--moist, antimicrobial, and biomaterial-based--is set to boost efficiency and reduce costs. Technologic advances are expected to promote a range of next-generation solutions comprising tissue-engineered wound management.

Europe is the global leader in the use of moist wound dressings, with hydrocolloids and foam dressings contributing the bulk of revenues. Rising concerns regarding infected wounds and heightened awareness of the benefits of incorporating silver into wound dressings for reduced healing time and lowered risk of infection are likely to be growth drivers in the antimicrobial dressings market. However, the high costs of antimicrobial dressings are likely to pose a challenge. The biomaterials-based wound dressings market is limited in size due to the high cost of these products.

"Continued growth in the overall market is likely to be affected by the ability to establish the efficacy of tissue-engineered products as well as the ability to educate the medical community on the need to adopt new technologies,” explained Tanya Pullen, program manager, medical devices, Frost & Sullivan.






Related Links:
Frost & Sullivan